ONCY Stock Analysis: Buy, Sell, or Hold?
ONCY - Oncolytics Biotech, Inc. Common Shares
$0.92
-0.02 (-2.06%)
▼
5d:
-2.95%
30d:
+13.84%
90d:
-0.22%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ONCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ONCY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ONCY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: ONCY is currently trading at $0.92, which is considered slightly high relative to its 30-day fair value range of $0.80 to $0.95.
Technical Outlook: Technically, ONCY is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.18.
Market Sentiment: ONCY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.92 (+433.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ONCY is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.18.
Market Sentiment: ONCY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.92 (+433.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.80 -
$0.95
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 433.9% below Wall St target ($4.92)
Trading Range Analysis
30-Day Trading Range
$0.80 -
$0.95
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.80
Resistance Level
$1.18
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.75
Wall Street Target
$4.92
(+433.9%)
Share & Embed Analysis
Last updated: June 24, 2026 11:50 PM ET
Data refreshes hourly during market hours. Next update: 12:50 AM
Data refreshes hourly during market hours. Next update: 12:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCY showing a specific setup today?
Insider Activity (6 Months)
14
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jared Kelly
BUY
5050 shares
2026-03-12
James T Parsons
BUY
10000 shares
2026-03-11
Allison Hagerman
BUY
10000 shares
2026-02-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 61 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 61 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 66 BUY |
